{"transactions":[{"id":2210191,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":125481,"kind":"person","name":"WANG HUIMIN","position":1,"cik":"0001204553","reported_name":"WANG HUIMIN","relationship":{"officer":true,"officer_title":"CVP, Japan & Intercontinental"}}],"security":"Employee Stock Option (Right to Acquire)","published_at":"2022-07-08T22:21:01.000Z","date":"2022-07-08","kind":"exercise","acquired":false,"shares":3675,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":25725,"derivative":{"exercise_price":35.1967,"exercise_date":"2016-06-12","expiration_date":"2023-05-11","underlying":"Common Stock","underlying_shares":3675},"source":{"system":"sec-edgar","filing":"0001225208-22-008744","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520822008744/doc4.xml","form_type":"4"}},{"id":2210190,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":125481,"kind":"person","name":"WANG HUIMIN","position":1,"cik":"0001204553","reported_name":"WANG HUIMIN","relationship":{"officer":true,"officer_title":"CVP, Japan & Intercontinental"}}],"security":"Common Stock","published_at":"2022-07-08T22:21:01.000Z","date":"2022-07-08","kind":"sale","acquired":false,"shares":3675,"price":97.6,"value":358680.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on February 4, 2022."}],"balance_after":99381.2782,"source":{"system":"sec-edgar","filing":"0001225208-22-008744","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520822008744/doc4.xml","form_type":"4"}},{"id":2210189,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":125481,"kind":"person","name":"WANG HUIMIN","position":1,"cik":"0001204553","reported_name":"WANG HUIMIN","relationship":{"officer":true,"officer_title":"CVP, Japan & Intercontinental"}}],"security":"Common Stock","published_at":"2022-07-08T22:21:01.000Z","date":"2022-07-08","kind":"exercise","acquired":true,"shares":3675,"price":35.1967,"value":129347.8725,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on February 4, 2022."}],"balance_after":103056.2782,"source":{"system":"sec-edgar","filing":"0001225208-22-008744","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520822008744/doc4.xml","form_type":"4"}},{"id":2233130,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":125481,"kind":"person","name":"WANG HUIMIN","position":1,"cik":"0001204553","reported_name":"WANG HUIMIN","relationship":{"officer":true,"officer_title":"CVP, Japan & Intercontinental"}}],"security":"Employee Stock Option (Right to Acquire)","published_at":"2022-06-14T23:44:03.000Z","date":"2022-06-14","kind":"exercise","acquired":false,"shares":3675,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":29400,"derivative":{"exercise_price":35.1967,"exercise_date":"2016-06-12","expiration_date":"2023-05-11","underlying":"Common Stock","underlying_shares":3675},"source":{"system":"sec-edgar","filing":"0001225208-22-008105","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520822008105/doc4.xml","form_type":"4"}},{"id":2233129,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":125481,"kind":"person","name":"WANG HUIMIN","position":1,"cik":"0001204553","reported_name":"WANG HUIMIN","relationship":{"officer":true,"officer_title":"CVP, Japan & Intercontinental"}}],"security":"Common Stock","published_at":"2022-06-14T23:44:03.000Z","date":"2022-06-14","kind":"sale","acquired":false,"shares":3675,"price":87.75,"value":322481.25,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on February 4, 2022."}],"balance_after":99336.8018,"source":{"system":"sec-edgar","filing":"0001225208-22-008105","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520822008105/doc4.xml","form_type":"4"}},{"id":2233128,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":125481,"kind":"person","name":"WANG HUIMIN","position":1,"cik":"0001204553","reported_name":"WANG HUIMIN","relationship":{"officer":true,"officer_title":"CVP, Japan & Intercontinental"}}],"security":"Common Stock","published_at":"2022-06-14T23:44:03.000Z","date":"2022-06-14","kind":"exercise","acquired":true,"shares":3675,"price":35.1967,"value":129347.8725,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on February 4, 2022."}],"balance_after":103011.8018,"source":{"system":"sec-edgar","filing":"0001225208-22-008105","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520822008105/doc4.xml","form_type":"4"}},{"id":2268872,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":125481,"kind":"person","name":"WANG HUIMIN","position":1,"cik":"0001204553","reported_name":"WANG HUIMIN","relationship":{"officer":true,"officer_title":"CVP, Japan & Intercontinental"}}],"security":"Common Stock","published_at":"2022-05-18T01:17:03.000Z","date":"2022-05-17","kind":"tax_withholding","acquired":false,"shares":963,"price":95.93,"value":92380.59,"ownership":{"direct":true},"balance_after":99336.8018,"source":{"system":"sec-edgar","filing":"0001225208-22-007141","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520822007141/doc4.xml","form_type":"4"}},{"id":2276601,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":125481,"kind":"person","name":"WANG HUIMIN","position":1,"cik":"0001204553","reported_name":"WANG HUIMIN","relationship":{"officer":true,"officer_title":"CVP, Japan & Intercontinental"}}],"security":"Employee Stock Option (Right to Acquire)","published_at":"2022-05-11T00:54:38.000Z","date":"2022-05-09","kind":"exercise","acquired":false,"shares":3675,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":33075,"derivative":{"exercise_price":35.1967,"exercise_date":"2016-06-12","expiration_date":"2023-05-11","underlying":"Common Stock","underlying_shares":3675},"source":{"system":"sec-edgar","filing":"0001225208-22-006815","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520822006815/doc4.xml","form_type":"4"}},{"id":2276600,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":125481,"kind":"person","name":"WANG HUIMIN","position":1,"cik":"0001204553","reported_name":"WANG HUIMIN","relationship":{"officer":true,"officer_title":"CVP, Japan & Intercontinental"}}],"security":"Performance Rights","published_at":"2022-05-11T00:54:38.000Z","date":"2022-05-08","kind":"exercise","acquired":false,"shares":6956,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"On May 8, 2019, the Reporting Person was granted a target number of shares covered by restricted stock units with performance-based vesting requirements over a three-year performance period. On May 2, 2022, the Compensation Committee of the Board of Directors determined that 175% of the target number of shares would vest as of May 8, 2022, and the actual number of shares vested are reflected on this Form 4."}],"balance_after":0,"derivative":{"exercise_date":"2022-05-08","expiration_date":"2026-05-07","underlying":"Common Stock","underlying_shares":6956},"source":{"system":"sec-edgar","filing":"0001225208-22-006815","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520822006815/doc4.xml","form_type":"4"}},{"id":2276599,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":125481,"kind":"person","name":"WANG HUIMIN","position":1,"cik":"0001204553","reported_name":"WANG HUIMIN","relationship":{"officer":true,"officer_title":"CVP, Japan & Intercontinental"}}],"security":"Common Stock","published_at":"2022-05-11T00:54:38.000Z","date":"2022-05-09","kind":"sale","acquired":false,"shares":3675,"price":98.71,"value":362759.25,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on February 4, 2022."}],"balance_after":100299.8018,"source":{"system":"sec-edgar","filing":"0001225208-22-006815","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520822006815/doc4.xml","form_type":"4"}},{"id":2276598,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":125481,"kind":"person","name":"WANG HUIMIN","position":1,"cik":"0001204553","reported_name":"WANG HUIMIN","relationship":{"officer":true,"officer_title":"CVP, Japan & Intercontinental"}}],"security":"Common Stock","published_at":"2022-05-11T00:54:38.000Z","date":"2022-05-09","kind":"exercise","acquired":true,"shares":3675,"price":35.1967,"value":129347.8725,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on February 4, 2022."}],"balance_after":103974.8018,"source":{"system":"sec-edgar","filing":"0001225208-22-006815","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520822006815/doc4.xml","form_type":"4"}},{"id":2276597,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":125481,"kind":"person","name":"WANG HUIMIN","position":1,"cik":"0001204553","reported_name":"WANG HUIMIN","relationship":{"officer":true,"officer_title":"CVP, Japan & Intercontinental"}}],"security":"Common Stock","published_at":"2022-05-11T00:54:38.000Z","date":"2022-05-08","kind":"tax_withholding","acquired":false,"shares":4210,"price":100.52,"value":423189.2,"ownership":{"direct":true},"balance_after":100299.8018,"source":{"system":"sec-edgar","filing":"0001225208-22-006815","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520822006815/doc4.xml","form_type":"4"}},{"id":2276596,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":125481,"kind":"person","name":"WANG HUIMIN","position":1,"cik":"0001204553","reported_name":"WANG HUIMIN","relationship":{"officer":true,"officer_title":"CVP, Japan & Intercontinental"}}],"security":"Common Stock","published_at":"2022-05-11T00:54:38.000Z","date":"2022-05-08","kind":"exercise","acquired":true,"shares":6956,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"On May 8, 2019, the Reporting Person was granted a target number of shares covered by restricted stock units with performance-based vesting requirements over a three-year performance period. On May 2, 2022, the Compensation Committee of the Board of Directors determined that 175% of the target number of shares would vest as of May 8, 2022, and the actual number of shares vested are reflected on this Form 4."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On May 8, 2019, the Reporting Person was granted a target number of shares covered by restricted stock units with performance-based vesting requirements over a three-year performance period. On May 2, 2022, the Compensation Committee of the Board of Directors determined that 175% of the target number of shares would vest as of May 8, 2022, and the actual number of shares vested are reflected on this Form 4."}],"balance_after":104509.8018,"source":{"system":"sec-edgar","filing":"0001225208-22-006815","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520822006815/doc4.xml","form_type":"4"}},{"id":2276595,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":125481,"kind":"person","name":"WANG HUIMIN","position":1,"cik":"0001204553","reported_name":"WANG HUIMIN","relationship":{"officer":true,"officer_title":"CVP, Japan & Intercontinental"}}],"security":"Common Stock","published_at":"2022-05-11T00:54:38.000Z","date":"2022-05-07","kind":"tax_withholding","acquired":false,"shares":363,"price":100.52,"value":36488.76,"ownership":{"direct":true},"balance_after":97553.8018,"source":{"system":"sec-edgar","filing":"0001225208-22-006815","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520822006815/doc4.xml","form_type":"4"}},{"id":2281175,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":125481,"kind":"person","name":"WANG HUIMIN","position":1,"cik":"0001204553","reported_name":"WANG HUIMIN","relationship":{"officer":true,"officer_title":"CVP, Japan & Intercontinental"}}],"security":"Common Stock","published_at":"2022-05-05T21:54:06.000Z","date":"2022-05-04","kind":"tax_withholding","acquired":false,"shares":307,"price":105.93,"value":32520.51,"ownership":{"direct":true},"balance_after":97916.8018,"source":{"system":"sec-edgar","filing":"0001225208-22-006586","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520822006586/doc4.xml","form_type":"4"}},{"id":2300609,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":125481,"kind":"person","name":"WANG HUIMIN","position":1,"cik":"0001204553","reported_name":"WANG HUIMIN","relationship":{"officer":true,"officer_title":"CVP, Japan & Intercontinental"}}],"security":"Employee Stock Option (Right to Acquire)","published_at":"2022-04-08T21:40:33.000Z","date":"2022-04-08","kind":"exercise","acquired":false,"shares":3675,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":36750,"derivative":{"exercise_price":35.1967,"exercise_date":"2016-06-12","expiration_date":"2023-05-11","underlying":"Common Stock","underlying_shares":3675},"source":{"system":"sec-edgar","filing":"0001225208-22-005740","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520822005740/doc4.xml","form_type":"4"}},{"id":2300608,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":125481,"kind":"person","name":"WANG HUIMIN","position":1,"cik":"0001204553","reported_name":"WANG HUIMIN","relationship":{"officer":true,"officer_title":"CVP, Japan & Intercontinental"}}],"security":"Common Stock","published_at":"2022-04-08T21:40:33.000Z","date":"2022-04-08","kind":"sale","acquired":false,"shares":3675,"price":123.07,"value":452282.25,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on February 4, 2022."}],"balance_after":98223.8018,"source":{"system":"sec-edgar","filing":"0001225208-22-005740","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520822005740/doc4.xml","form_type":"4"}},{"id":2300607,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":125481,"kind":"person","name":"WANG HUIMIN","position":1,"cik":"0001204553","reported_name":"WANG HUIMIN","relationship":{"officer":true,"officer_title":"CVP, Japan & Intercontinental"}}],"security":"Common Stock","published_at":"2022-04-08T21:40:33.000Z","date":"2022-04-08","kind":"exercise","acquired":true,"shares":3675,"price":35.1967,"value":129347.8725,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on February 4, 2022."}],"balance_after":101898.8018,"source":{"system":"sec-edgar","filing":"0001225208-22-005740","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520822005740/doc4.xml","form_type":"4"}},{"id":2345325,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":125481,"kind":"person","name":"WANG HUIMIN","position":1,"cik":"0001204553","reported_name":"WANG HUIMIN","relationship":{"officer":true,"officer_title":"CVP, Japan & Intercontinental"}}],"security":"Employee Stock Option (Right to Acquire)","published_at":"2022-03-09T01:27:51.000Z","date":"2022-03-08","kind":"exercise","acquired":false,"shares":3675,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":40425,"derivative":{"exercise_price":35.1967,"exercise_date":"2016-06-12","expiration_date":"2023-05-11","underlying":"Common Stock","underlying_shares":3675},"source":{"system":"sec-edgar","filing":"0001225208-22-004393","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520822004393/doc4.xml","form_type":"4"}},{"id":2345324,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":125481,"kind":"person","name":"WANG HUIMIN","position":1,"cik":"0001204553","reported_name":"WANG HUIMIN","relationship":{"officer":true,"officer_title":"CVP, Japan & Intercontinental"}}],"security":"Common Stock","published_at":"2022-03-09T01:27:51.000Z","date":"2022-03-08","kind":"sale","acquired":false,"shares":3675,"price":107.6,"value":395430.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on February 4, 2022."}],"balance_after":98026.8935,"source":{"system":"sec-edgar","filing":"0001225208-22-004393","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520822004393/doc4.xml","form_type":"4"}},{"id":2345323,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":125481,"kind":"person","name":"WANG HUIMIN","position":1,"cik":"0001204553","reported_name":"WANG HUIMIN","relationship":{"officer":true,"officer_title":"CVP, Japan & Intercontinental"}}],"security":"Common Stock","published_at":"2022-03-09T01:27:51.000Z","date":"2022-03-08","kind":"exercise","acquired":true,"shares":3675,"price":35.1967,"value":129347.8725,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on February 4, 2022."}],"balance_after":101701.8935,"source":{"system":"sec-edgar","filing":"0001225208-22-004393","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520822004393/doc4.xml","form_type":"4"}},{"id":2408869,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":125481,"kind":"person","name":"WANG HUIMIN","position":1,"cik":"0001204553","reported_name":"WANG HUIMIN","relationship":{"officer":true,"officer_title":"CVP, Japan & Intercontinental"}}],"security":"Employee Stock Option (Right to Acquire)","published_at":"2022-02-09T01:12:13.000Z","date":"2022-02-08","kind":"exercise","acquired":false,"shares":6350,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":0,"derivative":{"exercise_price":21.76,"exercise_date":"2015-06-14","expiration_date":"2022-05-13","underlying":"Common Stock","underlying_shares":6350},"source":{"system":"sec-edgar","filing":"0001225208-22-001655","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520822001655/doc4.xml","form_type":"4"}},{"id":2408868,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":125481,"kind":"person","name":"WANG HUIMIN","position":1,"cik":"0001204553","reported_name":"WANG HUIMIN","relationship":{"officer":true,"officer_title":"CVP, Japan & Intercontinental"}}],"security":"Common Stock","published_at":"2022-02-09T01:12:13.000Z","date":"2022-02-08","kind":"sale","acquired":false,"shares":6350,"price":110.2,"value":699770.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on February 4, 2021."}],"balance_after":98026.8935,"source":{"system":"sec-edgar","filing":"0001225208-22-001655","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520822001655/doc4.xml","form_type":"4"}},{"id":2408867,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":125481,"kind":"person","name":"WANG HUIMIN","position":1,"cik":"0001204553","reported_name":"WANG HUIMIN","relationship":{"officer":true,"officer_title":"CVP, Japan & Intercontinental"}}],"security":"Common Stock","published_at":"2022-02-09T01:12:13.000Z","date":"2022-02-08","kind":"exercise","acquired":true,"shares":6350,"price":21.76,"value":138176.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on February 4, 2021."}],"balance_after":104376.8935,"source":{"system":"sec-edgar","filing":"0001225208-22-001655","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520822001655/doc4.xml","form_type":"4"}},{"id":2440568,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":125481,"kind":"person","name":"WANG HUIMIN","position":1,"cik":"0001204553","reported_name":"WANG HUIMIN","relationship":{"officer":true,"officer_title":"CVP, Japan & Intercontinental"}}],"security":"Employee Stock Option (Right to Acquire)","published_at":"2022-01-07T23:06:54.000Z","date":"2022-01-07","kind":"exercise","acquired":false,"shares":6350,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":6350,"derivative":{"exercise_price":21.76,"exercise_date":"2015-06-14","expiration_date":"2022-05-13","underlying":"Common Stock","underlying_shares":6350},"source":{"system":"sec-edgar","filing":"0001225208-22-000615","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520822000615/doc4.xml","form_type":"4"}},{"id":2440567,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":125481,"kind":"person","name":"WANG HUIMIN","position":1,"cik":"0001204553","reported_name":"WANG HUIMIN","relationship":{"officer":true,"officer_title":"CVP, Japan & Intercontinental"}}],"security":"Common Stock","published_at":"2022-01-07T23:06:54.000Z","date":"2022-01-07","kind":"sale","acquired":false,"shares":6350,"price":122.16,"value":775716.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on February 4, 2021."}],"balance_after":98026.8935,"source":{"system":"sec-edgar","filing":"0001225208-22-000615","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520822000615/doc4.xml","form_type":"4"}},{"id":2440566,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":125481,"kind":"person","name":"WANG HUIMIN","position":1,"cik":"0001204553","reported_name":"WANG HUIMIN","relationship":{"officer":true,"officer_title":"CVP, Japan & Intercontinental"}}],"security":"Common Stock","published_at":"2022-01-07T23:06:54.000Z","date":"2022-01-07","kind":"exercise","acquired":true,"shares":6350,"price":21.76,"value":138176.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on February 4, 2021."}],"balance_after":104376.8935,"source":{"system":"sec-edgar","filing":"0001225208-22-000615","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520822000615/doc4.xml","form_type":"4"}},{"id":2477703,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":125481,"kind":"person","name":"WANG HUIMIN","position":1,"cik":"0001204553","reported_name":"WANG HUIMIN","relationship":{"officer":true,"officer_title":"CVP, Japan & Intercontinental"}}],"security":"Employee Stock Option (Right to Acquire)","published_at":"2021-12-11T01:27:44.000Z","date":"2021-12-10","kind":"exercise","acquired":false,"shares":6350,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":12700,"derivative":{"exercise_price":21.76,"exercise_date":"2015-06-14","expiration_date":"2022-05-13","underlying":"Common Stock","underlying_shares":6350},"source":{"system":"sec-edgar","filing":"0001225208-21-014809","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520821014809/doc4.xml","form_type":"4"}},{"id":2477702,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":125481,"kind":"person","name":"WANG HUIMIN","position":1,"cik":"0001204553","reported_name":"WANG HUIMIN","relationship":{"officer":true,"officer_title":"CVP, Japan & Intercontinental"}}],"security":"Common Stock","published_at":"2021-12-11T01:27:44.000Z","date":"2021-12-10","kind":"sale","acquired":false,"shares":5950,"price":121.4625,"value":722701.875,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on February 4, 2021."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"This transaction was executed in multiple trades at prices ranging from $121.01 to $121.88. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide, upon request by the SEC staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":98026.8935,"source":{"system":"sec-edgar","filing":"0001225208-21-014809","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520821014809/doc4.xml","form_type":"4"}},{"id":2477701,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":125481,"kind":"person","name":"WANG HUIMIN","position":1,"cik":"0001204553","reported_name":"WANG HUIMIN","relationship":{"officer":true,"officer_title":"CVP, Japan & Intercontinental"}}],"security":"Common Stock","published_at":"2021-12-11T01:27:44.000Z","date":"2021-12-10","kind":"sale","acquired":false,"shares":400,"price":122.0425,"value":48817.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on February 4, 2021."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This transaction was executed in multiple trades at prices ranging from $122.01 to $122.09. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide, upon request by the SEC staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":103976.8935,"source":{"system":"sec-edgar","filing":"0001225208-21-014809","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520821014809/doc4.xml","form_type":"4"}},{"id":2477700,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":125481,"kind":"person","name":"WANG HUIMIN","position":1,"cik":"0001204553","reported_name":"WANG HUIMIN","relationship":{"officer":true,"officer_title":"CVP, Japan & Intercontinental"}}],"security":"Common Stock","published_at":"2021-12-11T01:27:44.000Z","date":"2021-12-10","kind":"exercise","acquired":true,"shares":6350,"price":21.76,"value":138176.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on February 4, 2021."}],"balance_after":104376.8935,"source":{"system":"sec-edgar","filing":"0001225208-21-014809","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520821014809/doc4.xml","form_type":"4"}},{"id":2521845,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":125481,"kind":"person","name":"WANG HUIMIN","position":1,"cik":"0001204553","reported_name":"WANG HUIMIN","relationship":{"officer":true,"officer_title":"CVP, Japan & Intercontinental"}}],"security":"Employee Stock Option (Right to Acquire)","published_at":"2021-11-08T23:10:28.000Z","date":"2021-11-08","kind":"exercise","acquired":false,"shares":6350,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":19050,"derivative":{"exercise_price":21.76,"exercise_date":"2015-06-14","expiration_date":"2022-05-13","underlying":"Common Stock","underlying_shares":6350},"source":{"system":"sec-edgar","filing":"0001225208-21-013694","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520821013694/doc4.xml","form_type":"4"}},{"id":2521844,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":125481,"kind":"person","name":"WANG HUIMIN","position":1,"cik":"0001204553","reported_name":"WANG HUIMIN","relationship":{"officer":true,"officer_title":"CVP, Japan & Intercontinental"}}],"security":"Common Stock","published_at":"2021-11-08T23:10:28.000Z","date":"2021-11-08","kind":"sale","acquired":false,"shares":6350,"price":119.4,"value":758190.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on February 4, 2021."}],"balance_after":98026.8935,"source":{"system":"sec-edgar","filing":"0001225208-21-013694","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520821013694/doc4.xml","form_type":"4"}},{"id":2521843,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":125481,"kind":"person","name":"WANG HUIMIN","position":1,"cik":"0001204553","reported_name":"WANG HUIMIN","relationship":{"officer":true,"officer_title":"CVP, Japan & Intercontinental"}}],"security":"Common Stock","published_at":"2021-11-08T23:10:28.000Z","date":"2021-11-08","kind":"exercise","acquired":true,"shares":6350,"price":21.76,"value":138176.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on February 4, 2021."}],"balance_after":104376.8935,"source":{"system":"sec-edgar","filing":"0001225208-21-013694","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520821013694/doc4.xml","form_type":"4"}},{"id":2545767,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":125481,"kind":"person","name":"WANG HUIMIN","position":1,"cik":"0001204553","reported_name":"WANG HUIMIN","relationship":{"officer":true,"officer_title":"CVP, Japan & Intercontinental"}}],"security":"Employee Stock Option (Right to Acquire)","published_at":"2021-10-08T21:03:26.000Z","date":"2021-10-08","kind":"exercise","acquired":false,"shares":6350,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":25400,"derivative":{"exercise_price":21.76,"exercise_date":"2015-06-14","expiration_date":"2022-05-13","underlying":"Common Stock","underlying_shares":6350},"source":{"system":"sec-edgar","filing":"0001225208-21-013066","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520821013066/doc4.xml","form_type":"4"}},{"id":2545766,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":125481,"kind":"person","name":"WANG HUIMIN","position":1,"cik":"0001204553","reported_name":"WANG HUIMIN","relationship":{"officer":true,"officer_title":"CVP, Japan & Intercontinental"}}],"security":"Common Stock","published_at":"2021-10-08T21:03:26.000Z","date":"2021-10-08","kind":"sale","acquired":false,"shares":6350,"price":110.91,"value":704278.5,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on February 4, 2021."}],"balance_after":98026.8935,"source":{"system":"sec-edgar","filing":"0001225208-21-013066","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520821013066/doc4.xml","form_type":"4"}},{"id":2545765,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":125481,"kind":"person","name":"WANG HUIMIN","position":1,"cik":"0001204553","reported_name":"WANG HUIMIN","relationship":{"officer":true,"officer_title":"CVP, Japan & Intercontinental"}}],"security":"Common Stock","published_at":"2021-10-08T21:03:26.000Z","date":"2021-10-08","kind":"exercise","acquired":true,"shares":6350,"price":21.76,"value":138176.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on February 4, 2021."}],"balance_after":104376.8935,"source":{"system":"sec-edgar","filing":"0001225208-21-013066","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520821013066/doc4.xml","form_type":"4"}},{"id":2576429,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":125481,"kind":"person","name":"WANG HUIMIN","position":1,"cik":"0001204553","reported_name":"WANG HUIMIN","relationship":{"officer":true,"officer_title":"CVP, Japan & Intercontinental"}}],"security":"Employee Stock Option (Right to Acquire)","published_at":"2021-09-09T01:04:46.000Z","date":"2021-09-08","kind":"exercise","acquired":false,"shares":6350,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":31750,"derivative":{"exercise_price":21.76,"exercise_date":"2015-06-14","expiration_date":"2022-05-13","underlying":"Common Stock","underlying_shares":6350},"source":{"system":"sec-edgar","filing":"0001225208-21-012146","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520821012146/doc4.xml","form_type":"4"}},{"id":2576428,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":125481,"kind":"person","name":"WANG HUIMIN","position":1,"cik":"0001204553","reported_name":"WANG HUIMIN","relationship":{"officer":true,"officer_title":"CVP, Japan & Intercontinental"}}],"security":"Common Stock","published_at":"2021-09-09T01:04:46.000Z","date":"2021-09-08","kind":"sale","acquired":false,"shares":6350,"price":121.2515,"value":769947.025,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on February 4, 2021."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This transaction was executed in multiple trades at prices ranging from $120.9900 to $121.6800. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide, upon request by the SEC staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":98026.8935,"source":{"system":"sec-edgar","filing":"0001225208-21-012146","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520821012146/doc4.xml","form_type":"4"}},{"id":2576427,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":125481,"kind":"person","name":"WANG HUIMIN","position":1,"cik":"0001204553","reported_name":"WANG HUIMIN","relationship":{"officer":true,"officer_title":"CVP, Japan & Intercontinental"}}],"security":"Common Stock","published_at":"2021-09-09T01:04:46.000Z","date":"2021-09-08","kind":"exercise","acquired":true,"shares":6350,"price":21.76,"value":138176.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on February 4, 2021."}],"balance_after":104376.8935,"source":{"system":"sec-edgar","filing":"0001225208-21-012146","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520821012146/doc4.xml","form_type":"4"}},{"id":2610506,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":125481,"kind":"person","name":"WANG HUIMIN","position":1,"cik":"0001204553","reported_name":"WANG HUIMIN","relationship":{"officer":true,"officer_title":"CVP, Japan & Intercontinental"}}],"security":"Employee Stock Option (Right to Acquire)","published_at":"2021-08-10T00:11:08.000Z","date":"2021-08-09","kind":"exercise","acquired":false,"shares":6350,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":38100,"derivative":{"exercise_price":21.76,"exercise_date":"2015-06-14","expiration_date":"2022-05-13","underlying":"Common Stock","underlying_shares":6350},"source":{"system":"sec-edgar","filing":"0001225208-21-011337","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520821011337/doc4.xml","form_type":"4"}},{"id":2610505,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":125481,"kind":"person","name":"WANG HUIMIN","position":1,"cik":"0001204553","reported_name":"WANG HUIMIN","relationship":{"officer":true,"officer_title":"CVP, Japan & Intercontinental"}}],"security":"Common Stock","published_at":"2021-08-10T00:11:08.000Z","date":"2021-08-09","kind":"sale","acquired":false,"shares":6350,"price":115.54,"value":733679.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on February 4, 2021."}],"balance_after":98026.8935,"source":{"system":"sec-edgar","filing":"0001225208-21-011337","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520821011337/doc4.xml","form_type":"4"}},{"id":2610504,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":125481,"kind":"person","name":"WANG HUIMIN","position":1,"cik":"0001204553","reported_name":"WANG HUIMIN","relationship":{"officer":true,"officer_title":"CVP, Japan & Intercontinental"}}],"security":"Common Stock","published_at":"2021-08-10T00:11:08.000Z","date":"2021-08-09","kind":"exercise","acquired":true,"shares":6350,"price":21.76,"value":138176.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on February 4, 2021."}],"balance_after":104376.8935,"source":{"system":"sec-edgar","filing":"0001225208-21-011337","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520821011337/doc4.xml","form_type":"4"}},{"id":2638698,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":125481,"kind":"person","name":"WANG HUIMIN","position":1,"cik":"0001204553","reported_name":"WANG HUIMIN","relationship":{"officer":true,"officer_title":"CVP, Japan & Intercontinental"}}],"security":"Employee Stock Option (Right to Acquire)","published_at":"2021-07-09T00:18:03.000Z","date":"2021-07-08","kind":"exercise","acquired":false,"shares":6350,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":44450,"derivative":{"exercise_price":21.76,"exercise_date":"2015-06-14","expiration_date":"2022-05-13","underlying":"Common Stock","underlying_shares":6350},"source":{"system":"sec-edgar","filing":"0001225208-21-010518","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520821010518/doc4.xml","form_type":"4"}},{"id":2638697,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":125481,"kind":"person","name":"WANG HUIMIN","position":1,"cik":"0001204553","reported_name":"WANG HUIMIN","relationship":{"officer":true,"officer_title":"CVP, Japan & Intercontinental"}}],"security":"Common Stock","published_at":"2021-07-09T00:18:03.000Z","date":"2021-07-08","kind":"sale","acquired":false,"shares":6350,"price":106.72,"value":677672.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on February 4, 2021."}],"balance_after":98026.8935,"source":{"system":"sec-edgar","filing":"0001225208-21-010518","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520821010518/doc4.xml","form_type":"4"}},{"id":2638696,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":125481,"kind":"person","name":"WANG HUIMIN","position":1,"cik":"0001204553","reported_name":"WANG HUIMIN","relationship":{"officer":true,"officer_title":"CVP, Japan & Intercontinental"}}],"security":"Common Stock","published_at":"2021-07-09T00:18:03.000Z","date":"2021-07-08","kind":"exercise","acquired":true,"shares":6350,"price":21.76,"value":138176.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on February 4, 2021."}],"balance_after":104376.8935,"source":{"system":"sec-edgar","filing":"0001225208-21-010518","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520821010518/doc4.xml","form_type":"4"}},{"id":2669082,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":125481,"kind":"person","name":"WANG HUIMIN","position":1,"cik":"0001204553","reported_name":"WANG HUIMIN","relationship":{"officer":true,"officer_title":"CVP, Japan & Intercontinental"}}],"security":"Employee Stock Option (Right to Acquire)","published_at":"2021-06-16T00:33:03.000Z","date":"2021-06-15","kind":"exercise","acquired":false,"shares":6350,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":50800,"derivative":{"exercise_price":21.76,"exercise_date":"2015-06-14","expiration_date":"2022-05-13","underlying":"Common Stock","underlying_shares":6350},"source":{"system":"sec-edgar","filing":"0001225208-21-009448","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520821009448/doc4.xml","form_type":"4"}},{"id":2669081,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":125481,"kind":"person","name":"WANG HUIMIN","position":1,"cik":"0001204553","reported_name":"WANG HUIMIN","relationship":{"officer":true,"officer_title":"CVP, Japan & Intercontinental"}}],"security":"Common Stock","published_at":"2021-06-16T00:33:03.000Z","date":"2021-06-15","kind":"sale","acquired":false,"shares":6350,"price":101.0031,"value":641369.685,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on February 4, 2021."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This transaction was executed in multiple trades at prices ranging from $100.7150 to $101.1900. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide, upon request by the SEC staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":97889.8064,"source":{"system":"sec-edgar","filing":"0001225208-21-009448","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520821009448/doc4.xml","form_type":"4"}},{"id":2669080,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":125481,"kind":"person","name":"WANG HUIMIN","position":1,"cik":"0001204553","reported_name":"WANG HUIMIN","relationship":{"officer":true,"officer_title":"CVP, Japan & Intercontinental"}}],"security":"Common Stock","published_at":"2021-06-16T00:33:03.000Z","date":"2021-06-15","kind":"exercise","acquired":true,"shares":6350,"price":21.76,"value":138176.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on February 4, 2021."}],"balance_after":104239.8064,"source":{"system":"sec-edgar","filing":"0001225208-21-009448","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520821009448/doc4.xml","form_type":"4"}},{"id":2706193,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":125481,"kind":"person","name":"WANG HUIMIN","position":1,"cik":"0001204553","reported_name":"WANG HUIMIN","relationship":{"officer":true,"officer_title":"CVP, Japan & Intercontinental"}}],"security":"Performance Rights","published_at":"2021-05-19T20:31:04.000Z","date":"2021-05-17","kind":"exercise","acquired":false,"shares":8662,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"On May 17, 2018, the Reporting Person was granted a target number of shares covered by restricted stock units with performance-based vesting requirements over a three-year performance period. On May 3, 2021, the Compensation Committee of the Board of Directors determined that 175% of the target number of shares would vest as of May 17, 2021, and the actual number of shares vested are reflected on this Form 4."}],"balance_after":0,"derivative":{"exercise_date":"2021-05-17","expiration_date":"2025-05-16","underlying":"Common Stock","underlying_shares":8662},"source":{"system":"sec-edgar","filing":"0001225208-21-008302","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520821008302/doc4.xml","form_type":"4"}},{"id":2706192,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":125481,"kind":"person","name":"WANG HUIMIN","position":1,"cik":"0001204553","reported_name":"WANG HUIMIN","relationship":{"officer":true,"officer_title":"CVP, Japan & Intercontinental"}}],"security":"Common Stock","published_at":"2021-05-19T20:31:04.000Z","date":"2021-05-17","kind":"tax_withholding","acquired":false,"shares":4295,"price":89.49,"value":384359.55,"ownership":{"direct":true},"balance_after":97889.8064,"source":{"system":"sec-edgar","filing":"0001225208-21-008302","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520821008302/doc4.xml","form_type":"4"}},{"id":2706191,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":125481,"kind":"person","name":"WANG HUIMIN","position":1,"cik":"0001204553","reported_name":"WANG HUIMIN","relationship":{"officer":true,"officer_title":"CVP, Japan & Intercontinental"}}],"security":"Common Stock","published_at":"2021-05-19T20:31:04.000Z","date":"2021-05-17","kind":"tax_withholding","acquired":false,"shares":938,"price":89.49,"value":83941.62,"ownership":{"direct":true},"balance_after":102184.8064,"source":{"system":"sec-edgar","filing":"0001225208-21-008302","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520821008302/doc4.xml","form_type":"4"}},{"id":2706190,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":125481,"kind":"person","name":"WANG HUIMIN","position":1,"cik":"0001204553","reported_name":"WANG HUIMIN","relationship":{"officer":true,"officer_title":"CVP, Japan & Intercontinental"}}],"security":"Common Stock","published_at":"2021-05-19T20:31:04.000Z","date":"2021-05-17","kind":"exercise","acquired":true,"shares":8662,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"On May 17, 2018, the Reporting Person was granted a target number of shares covered by restricted stock units with performance-based vesting requirements over a three-year performance period. On May 3, 2021, the Compensation Committee of the Board of Directors determined that 175% of the target number of shares would vest as of May 17, 2021, and the actual number of shares vested are reflected on this Form 4."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On May 17, 2018, the Reporting Person was granted a target number of shares covered by restricted stock units with performance-based vesting requirements over a three-year performance period. On May 3, 2021, the Compensation Committee of the Board of Directors determined that 175% of the target number of shares would vest as of May 17, 2021, and the actual number of shares vested are reflected on this Form 4."}],"balance_after":103122.8064,"source":{"system":"sec-edgar","filing":"0001225208-21-008302","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520821008302/doc4.xml","form_type":"4"}},{"id":2717067,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":125481,"kind":"person","name":"WANG HUIMIN","position":1,"cik":"0001204553","reported_name":"WANG HUIMIN","relationship":{"officer":true,"officer_title":"CVP, Japan & Intercontinental"}}],"security":"Common Stock","published_at":"2021-05-13T01:38:11.000Z","date":"2021-05-11","kind":"tax_withholding","acquired":false,"shares":1090,"price":90.4,"value":98536.0,"ownership":{"direct":true},"balance_after":94460.8064,"source":{"system":"sec-edgar","filing":"0001225208-21-008058","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520821008058/doc4.xml","form_type":"4"}},{"id":2719258,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":125481,"kind":"person","name":"WANG HUIMIN","position":1,"cik":"0001204553","reported_name":"WANG HUIMIN","relationship":{"officer":true,"officer_title":"CVP, Japan & Intercontinental"}}],"security":"Common Stock","published_at":"2021-05-11T21:14:56.000Z","date":"2021-05-07","kind":"tax_withholding","acquired":false,"shares":362,"price":91.75,"value":33213.5,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Does not reflect transactions effected on May 7, 2021 pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on February 4, 2021, which transactions were reported on a Form 4 filed with the SEC on May 7, 2021. The actual amount of securities beneficially owned by the Reporting Person following transaction reported on this Form 4 is 95,550.8064."}],"balance_after":101900.8064,"source":{"system":"sec-edgar","filing":"0001225208-21-007974","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520821007974/doc4.xml","form_type":"4"}},{"id":2723751,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":125481,"kind":"person","name":"WANG HUIMIN","position":1,"cik":"0001204553","reported_name":"WANG HUIMIN","relationship":{"officer":true,"officer_title":"CVP, Japan & Intercontinental"}}],"security":"Employee Stock Option (Right to Acquire)","published_at":"2021-05-07T22:31:51.000Z","date":"2021-05-07","kind":"exercise","acquired":false,"shares":6350,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":57150,"derivative":{"exercise_price":21.76,"exercise_date":"2015-06-14","expiration_date":"2022-05-13","underlying":"Common Stock","underlying_shares":6350},"source":{"system":"sec-edgar","filing":"0001225208-21-007762","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520821007762/doc4.xml","form_type":"4"}},{"id":2723750,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":125481,"kind":"person","name":"WANG HUIMIN","position":1,"cik":"0001204553","reported_name":"WANG HUIMIN","relationship":{"officer":true,"officer_title":"CVP, Japan & Intercontinental"}}],"security":"Common Stock","published_at":"2021-05-07T22:31:51.000Z","date":"2021-05-07","kind":"sale","acquired":false,"shares":6350,"price":91.87,"value":583374.5,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on February 4, 2021."}],"balance_after":95912.8064,"source":{"system":"sec-edgar","filing":"0001225208-21-007762","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520821007762/doc4.xml","form_type":"4"}},{"id":2723749,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":125481,"kind":"person","name":"WANG HUIMIN","position":1,"cik":"0001204553","reported_name":"WANG HUIMIN","relationship":{"officer":true,"officer_title":"CVP, Japan & Intercontinental"}}],"security":"Common Stock","published_at":"2021-05-07T22:31:51.000Z","date":"2021-05-07","kind":"exercise","acquired":true,"shares":6350,"price":21.76,"value":138176.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on February 4, 2021."}],"balance_after":102262.8064,"source":{"system":"sec-edgar","filing":"0001225208-21-007762","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520821007762/doc4.xml","form_type":"4"}},{"id":2725465,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":125481,"kind":"person","name":"WANG HUIMIN","position":1,"cik":"0001204553","reported_name":"WANG HUIMIN","relationship":{"officer":true,"officer_title":"CVP, Japan & Intercontinental"}}],"security":"Performance Rights","published_at":"2021-05-07T01:12:13.000Z","date":"2021-05-04","kind":"grant","acquired":true,"shares":3075,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"Reflects the target number of shares (the Target Award) covered by restricted stock units granted under the Edwards Lifesciences Corporation Long-Term Stock Incentive Compensation Program on May 4, 2021 and scheduled to vest on May 4, 2024. The number of restricted stock units that vest will depend upon achievement of certain performance goals over a three-year performance period and will range from 0% to 175% of the Target Awards."}],"balance_after":3075,"derivative":{"exercise_date":"2024-05-04","expiration_date":"2028-05-03","underlying":"Common Stock","underlying_shares":3075},"source":{"system":"sec-edgar","filing":"0001225208-21-007710","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520821007710/doc4.xml","form_type":"4"}},{"id":2725464,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":125481,"kind":"person","name":"WANG HUIMIN","position":1,"cik":"0001204553","reported_name":"WANG HUIMIN","relationship":{"officer":true,"officer_title":"CVP, Japan & Intercontinental"}}],"security":"Employee Stock Option (Right to Acquire)","published_at":"2021-05-07T01:12:13.000Z","date":"2021-05-04","kind":"grant","acquired":true,"shares":24100,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"These options were granted on May 4, 2021 under the Edwards Lifesciences Corporation Long-Term Stock Incentive Compensation Program and are scheduled to become vested and exercisable commencing one month after the grant date in 36 approximately equal monthly installments."}],"balance_after":24100,"derivative":{"exercise_price":93.31,"exercise_date":"2022-05-04","expiration_date":"2028-05-03","underlying":"Common Stock","underlying_shares":24100},"source":{"system":"sec-edgar","filing":"0001225208-21-007710","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520821007710/doc4.xml","form_type":"4"}},{"id":2725463,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":125481,"kind":"person","name":"WANG HUIMIN","position":1,"cik":"0001204553","reported_name":"WANG HUIMIN","relationship":{"officer":true,"officer_title":"CVP, Japan & Intercontinental"}}],"security":"Common Stock","published_at":"2021-05-07T01:12:13.000Z","date":"2021-05-04","kind":"grant","acquired":true,"shares":2475,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These restricted stock units were granted on May 4, 2021 under the Edwards Lifesciences Corporation Long-Term Stock Incentive Compensation Program and are scheduled to become vested and exercisable commencing one year after the grant date in four equal annual installments."}],"balance_after":95912.8064,"source":{"system":"sec-edgar","filing":"0001225208-21-007710","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520821007710/doc4.xml","form_type":"4"}},{"id":2753306,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":125481,"kind":"person","name":"WANG HUIMIN","position":1,"cik":"0001204553","reported_name":"WANG HUIMIN","relationship":{"officer":true,"officer_title":"CVP, Japan & Intercontinental"}}],"security":"Employee Stock Option (Right to Acquire)","published_at":"2021-04-09T00:00:59.000Z","date":"2021-04-08","kind":"exercise","acquired":false,"shares":6350,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":63500,"derivative":{"exercise_price":21.76,"exercise_date":"2015-06-14","expiration_date":"2022-05-13","underlying":"Common Stock","underlying_shares":6350},"source":{"system":"sec-edgar","filing":"0001225208-21-006690","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520821006690/doc4.xml","form_type":"4"}},{"id":2753305,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":125481,"kind":"person","name":"WANG HUIMIN","position":1,"cik":"0001204553","reported_name":"WANG HUIMIN","relationship":{"officer":true,"officer_title":"CVP, Japan & Intercontinental"}}],"security":"Common Stock","published_at":"2021-04-09T00:00:59.000Z","date":"2021-04-08","kind":"sale","acquired":false,"shares":6350,"price":84.88,"value":538988.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on February 4, 2021."}],"balance_after":93437.8064,"source":{"system":"sec-edgar","filing":"0001225208-21-006690","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520821006690/doc4.xml","form_type":"4"}},{"id":2753304,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":125481,"kind":"person","name":"WANG HUIMIN","position":1,"cik":"0001204553","reported_name":"WANG HUIMIN","relationship":{"officer":true,"officer_title":"CVP, Japan & Intercontinental"}}],"security":"Common Stock","published_at":"2021-04-09T00:00:59.000Z","date":"2021-04-08","kind":"exercise","acquired":true,"shares":6350,"price":21.76,"value":138176.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on February 4, 2021."}],"balance_after":99787.8064,"source":{"system":"sec-edgar","filing":"0001225208-21-006690","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520821006690/doc4.xml","form_type":"4"}},{"id":2803860,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":125481,"kind":"person","name":"WANG HUIMIN","position":1,"cik":"0001204553","reported_name":"WANG HUIMIN","relationship":{"officer":true,"officer_title":"CVP, Japan & Intercontinental"}}],"security":"Employee Stock Option (Right to Acquire)","published_at":"2021-03-09T01:06:02.000Z","date":"2021-03-08","kind":"exercise","acquired":false,"shares":6350,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":69850,"derivative":{"exercise_price":21.76,"exercise_date":"2015-06-14","expiration_date":"2022-05-13","underlying":"Common Stock","underlying_shares":6350},"source":{"system":"sec-edgar","filing":"0001225208-21-004871","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520821004871/doc4.xml","form_type":"4"}},{"id":2803859,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":125481,"kind":"person","name":"WANG HUIMIN","position":1,"cik":"0001204553","reported_name":"WANG HUIMIN","relationship":{"officer":true,"officer_title":"CVP, Japan & Intercontinental"}}],"security":"Common Stock","published_at":"2021-03-09T01:06:02.000Z","date":"2021-03-08","kind":"sale","acquired":false,"shares":6350,"price":81.37,"value":516699.5,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on February 4, 2021."}],"balance_after":93213.1404,"source":{"system":"sec-edgar","filing":"0001225208-21-004871","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520821004871/doc4.xml","form_type":"4"}},{"id":2803858,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":125481,"kind":"person","name":"WANG HUIMIN","position":1,"cik":"0001204553","reported_name":"WANG HUIMIN","relationship":{"officer":true,"officer_title":"CVP, Japan & Intercontinental"}}],"security":"Common Stock","published_at":"2021-03-09T01:06:02.000Z","date":"2021-03-08","kind":"exercise","acquired":true,"shares":6350,"price":21.76,"value":138176.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on February 4, 2021."}],"balance_after":99563.1404,"source":{"system":"sec-edgar","filing":"0001225208-21-004871","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520821004871/doc4.xml","form_type":"4"}},{"id":2867342,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":125481,"kind":"person","name":"WANG HUIMIN","position":1,"cik":"0001204553","reported_name":"WANG HUIMIN","relationship":{"officer":true,"officer_title":"CVP, Japan & Intercontinental"}}],"security":"Employee Stock Option (Right to Acquire)","published_at":"2021-02-12T02:24:55.000Z","date":"2021-02-11","kind":"exercise","acquired":false,"shares":11661,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":0,"derivative":{"exercise_price":13.98,"exercise_date":"2015-05-08","expiration_date":"2021-05-07","underlying":"Common Stock","underlying_shares":11661},"source":{"system":"sec-edgar","filing":"0001225208-21-002276","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520821002276/doc4.xml","form_type":"4"}},{"id":2867341,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":125481,"kind":"person","name":"WANG HUIMIN","position":1,"cik":"0001204553","reported_name":"WANG HUIMIN","relationship":{"officer":true,"officer_title":"CVP, Japan & Intercontinental"}}],"security":"Common Stock","published_at":"2021-02-12T02:24:55.000Z","date":"2021-02-11","kind":"sale","acquired":false,"shares":11745,"price":86.81,"value":1019583.45,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on February 28, 2020."}],"balance_after":93213.1404,"source":{"system":"sec-edgar","filing":"0001225208-21-002276","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520821002276/doc4.xml","form_type":"4"}},{"id":2867340,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":125481,"kind":"person","name":"WANG HUIMIN","position":1,"cik":"0001204553","reported_name":"WANG HUIMIN","relationship":{"officer":true,"officer_title":"CVP, Japan & Intercontinental"}}],"security":"Common Stock","published_at":"2021-02-12T02:24:55.000Z","date":"2021-02-11","kind":"exercise","acquired":true,"shares":11661,"price":13.98,"value":163020.78,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on February 28, 2020."}],"balance_after":104958.1404,"source":{"system":"sec-edgar","filing":"0001225208-21-002276","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520821002276/doc4.xml","form_type":"4"}},{"id":2906451,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":125481,"kind":"person","name":"WANG HUIMIN","position":1,"cik":"0001204553","reported_name":"WANG HUIMIN","relationship":{"officer":true,"officer_title":"CVP, Japan & Intercontinental"}}],"security":"Employee Stock Option (Right to Acquire)","published_at":"2021-01-16T02:50:42.000Z","date":"2021-01-15","kind":"exercise","acquired":false,"shares":11649,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":11661,"derivative":{"exercise_price":13.98,"exercise_date":"2015-05-08","expiration_date":"2021-05-07","underlying":"Common Stock","underlying_shares":11649},"source":{"system":"sec-edgar","filing":"0001225208-21-000867","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520821000867/doc4.xml","form_type":"4"}},{"id":2906450,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":125481,"kind":"person","name":"WANG HUIMIN","position":1,"cik":"0001204553","reported_name":"WANG HUIMIN","relationship":{"officer":true,"officer_title":"CVP, Japan & Intercontinental"}}],"security":"Common Stock","published_at":"2021-01-16T02:50:42.000Z","date":"2021-01-15","kind":"sale","acquired":false,"shares":11730,"price":87.27,"value":1023677.1,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on February 28, 2020."}],"balance_after":93297.1404,"source":{"system":"sec-edgar","filing":"0001225208-21-000867","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520821000867/doc4.xml","form_type":"4"}},{"id":2906449,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":125481,"kind":"person","name":"WANG HUIMIN","position":1,"cik":"0001204553","reported_name":"WANG HUIMIN","relationship":{"officer":true,"officer_title":"CVP, Japan & Intercontinental"}}],"security":"Common Stock","published_at":"2021-01-16T02:50:42.000Z","date":"2021-01-15","kind":"exercise","acquired":true,"shares":11649,"price":13.98,"value":162853.02,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on February 28, 2020."}],"balance_after":105027.1404,"source":{"system":"sec-edgar","filing":"0001225208-21-000867","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520821000867/doc4.xml","form_type":"4"}},{"id":2947141,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":125481,"kind":"person","name":"WANG HUIMIN","position":1,"cik":"0001204553","reported_name":"WANG HUIMIN","relationship":{"officer":true,"officer_title":"CVP, Japan & Intercontinental"}}],"security":"Employee Stock Option (Right to Acquire)","published_at":"2020-12-14T23:36:59.000Z","date":"2020-12-14","kind":"exercise","acquired":false,"shares":11649,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":23310,"derivative":{"exercise_price":13.98,"exercise_date":"2015-05-08","expiration_date":"2021-05-07","underlying":"Common Stock","underlying_shares":11649},"source":{"system":"sec-edgar","filing":"0001225208-20-014704","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520820014704/doc4.xml","form_type":"4"}},{"id":2947140,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":125481,"kind":"person","name":"WANG HUIMIN","position":1,"cik":"0001204553","reported_name":"WANG HUIMIN","relationship":{"officer":true,"officer_title":"CVP, Japan & Intercontinental"}}],"security":"Common Stock","published_at":"2020-12-14T23:36:59.000Z","date":"2020-12-14","kind":"sale","acquired":false,"shares":11396,"price":84.5183,"value":963170.5468,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on February 28, 2020."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This transaction was executed in multiple trades at prices ranging from $84.0600 to $85.0300.  The price reported above reflects the weighted average sale price.  The Reporting Person hereby undertakes to provide, upon request by the SEC staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":93378.1404,"source":{"system":"sec-edgar","filing":"0001225208-20-014704","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520820014704/doc4.xml","form_type":"4"}},{"id":2947139,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":125481,"kind":"person","name":"WANG HUIMIN","position":1,"cik":"0001204553","reported_name":"WANG HUIMIN","relationship":{"officer":true,"officer_title":"CVP, Japan & Intercontinental"}}],"security":"Common Stock","published_at":"2020-12-14T23:36:59.000Z","date":"2020-12-14","kind":"sale","acquired":false,"shares":253,"price":85.15,"value":21542.95,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on February 28, 2020."}],"balance_after":104774.1404,"source":{"system":"sec-edgar","filing":"0001225208-20-014704","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520820014704/doc4.xml","form_type":"4"}},{"id":2947138,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":125481,"kind":"person","name":"WANG HUIMIN","position":1,"cik":"0001204553","reported_name":"WANG HUIMIN","relationship":{"officer":true,"officer_title":"CVP, Japan & Intercontinental"}}],"security":"Common Stock","published_at":"2020-12-14T23:36:59.000Z","date":"2020-12-14","kind":"sale","acquired":false,"shares":84,"price":84.53,"value":7100.52,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on February 28, 2020."}],"balance_after":105027.1404,"source":{"system":"sec-edgar","filing":"0001225208-20-014704","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520820014704/doc4.xml","form_type":"4"}},{"id":2947137,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":125481,"kind":"person","name":"WANG HUIMIN","position":1,"cik":"0001204553","reported_name":"WANG HUIMIN","relationship":{"officer":true,"officer_title":"CVP, Japan & Intercontinental"}}],"security":"Common Stock","published_at":"2020-12-14T23:36:59.000Z","date":"2020-12-14","kind":"exercise","acquired":true,"shares":11649,"price":13.98,"value":162853.02,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on February 28, 2020."}],"balance_after":105111.1404,"source":{"system":"sec-edgar","filing":"0001225208-20-014704","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520820014704/doc4.xml","form_type":"4"}},{"id":2984542,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":125481,"kind":"person","name":"WANG HUIMIN","position":1,"cik":"0001204553","reported_name":"WANG HUIMIN","relationship":{"officer":true,"officer_title":"CVP, Japan & Intercontinental"}}],"security":"Employee Stock Option (Right to Acquire)","published_at":"2020-11-12T23:35:31.000Z","date":"2020-11-11","kind":"exercise","acquired":false,"shares":11649,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":34959,"derivative":{"exercise_price":13.98,"exercise_date":"2015-05-08","expiration_date":"2021-05-07","underlying":"Common Stock","underlying_shares":11649},"source":{"system":"sec-edgar","filing":"0001225208-20-013488","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520820013488/doc4.xml","form_type":"4"}},{"id":2984541,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":125481,"kind":"person","name":"WANG HUIMIN","position":1,"cik":"0001204553","reported_name":"WANG HUIMIN","relationship":{"officer":true,"officer_title":"CVP, Japan & Intercontinental"}}],"security":"Common Stock","published_at":"2020-11-12T23:35:31.000Z","date":"2020-11-11","kind":"sale","acquired":false,"shares":8290,"price":81.014,"value":671606.06,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on February 28, 2020."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This transaction was executed in multiple trades at prices ranging from $80.5850 to $81.5200.  The price reported above reflects the weighted average sale price.  The Reporting Person hereby undertakes to provide, upon request by the SEC staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":93462.1404,"source":{"system":"sec-edgar","filing":"0001225208-20-013488","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520820013488/doc4.xml","form_type":"4"}},{"id":2984540,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":125481,"kind":"person","name":"WANG HUIMIN","position":1,"cik":"0001204553","reported_name":"WANG HUIMIN","relationship":{"officer":true,"officer_title":"CVP, Japan & Intercontinental"}}],"security":"Common Stock","published_at":"2020-11-12T23:35:31.000Z","date":"2020-11-11","kind":"sale","acquired":false,"shares":3359,"price":81.76,"value":274631.84,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on February 28, 2020."}],"balance_after":101752.1404,"source":{"system":"sec-edgar","filing":"0001225208-20-013488","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520820013488/doc4.xml","form_type":"4"}},{"id":2984539,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":125481,"kind":"person","name":"WANG HUIMIN","position":1,"cik":"0001204553","reported_name":"WANG HUIMIN","relationship":{"officer":true,"officer_title":"CVP, Japan & Intercontinental"}}],"security":"Common Stock","published_at":"2020-11-12T23:35:31.000Z","date":"2020-11-11","kind":"sale","acquired":false,"shares":81,"price":81.76,"value":6622.56,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on February 28, 2020."}],"balance_after":105111.1404,"source":{"system":"sec-edgar","filing":"0001225208-20-013488","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520820013488/doc4.xml","form_type":"4"}},{"id":2984538,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":125481,"kind":"person","name":"WANG HUIMIN","position":1,"cik":"0001204553","reported_name":"WANG HUIMIN","relationship":{"officer":true,"officer_title":"CVP, Japan & Intercontinental"}}],"security":"Common Stock","published_at":"2020-11-12T23:35:31.000Z","date":"2020-11-11","kind":"exercise","acquired":true,"shares":11649,"price":13.98,"value":162853.02,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on February 28, 2020."}],"balance_after":105192.1404,"source":{"system":"sec-edgar","filing":"0001225208-20-013488","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520820013488/doc4.xml","form_type":"4"}},{"id":3009560,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":125481,"kind":"person","name":"WANG HUIMIN","position":1,"cik":"0001204553","reported_name":"WANG HUIMIN","relationship":{"officer":true,"officer_title":"CVP, Japan & Intercontinental"}}],"security":"Employee Stock Option (Right to Acquire)","published_at":"2020-10-09T23:21:22.000Z","date":"2020-10-09","kind":"exercise","acquired":false,"shares":11649,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on February 28, 2020."}],"balance_after":46608,"derivative":{"exercise_price":13.98,"exercise_date":"2015-05-08","expiration_date":"2021-05-07","underlying":"Common Stock","underlying_shares":11649},"source":{"system":"sec-edgar","filing":"0001225208-20-012407","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520820012407/doc4.xml","form_type":"4"}},{"id":3009559,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":125481,"kind":"person","name":"WANG HUIMIN","position":1,"cik":"0001204553","reported_name":"WANG HUIMIN","relationship":{"officer":true,"officer_title":"CVP, Japan & Intercontinental"}}],"security":"Common Stock","published_at":"2020-10-09T23:21:22.000Z","date":"2020-10-09","kind":"sale","acquired":false,"shares":11649,"price":82.6002,"value":962209.7298,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on February 28, 2020."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This transaction was executed in multiple trades at prices ranging from $82.00 to $82.93.  The price reported above reflects the weighted average sale price.  The reporting person hereby undertakes to provide, upon request by the SEC staff, the issuer, or a security holder of the issuer, full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":93543.1404,"source":{"system":"sec-edgar","filing":"0001225208-20-012407","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520820012407/doc4.xml","form_type":"4"}},{"id":3009558,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":125481,"kind":"person","name":"WANG HUIMIN","position":1,"cik":"0001204553","reported_name":"WANG HUIMIN","relationship":{"officer":true,"officer_title":"CVP, Japan & Intercontinental"}}],"security":"Common Stock","published_at":"2020-10-09T23:21:22.000Z","date":"2020-10-09","kind":"sale","acquired":false,"shares":84,"price":82.18,"value":6903.12,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on February 28, 2020."}],"balance_after":105192.1404,"source":{"system":"sec-edgar","filing":"0001225208-20-012407","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520820012407/doc4.xml","form_type":"4"}},{"id":3009557,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":125481,"kind":"person","name":"WANG HUIMIN","position":1,"cik":"0001204553","reported_name":"WANG HUIMIN","relationship":{"officer":true,"officer_title":"CVP, Japan & Intercontinental"}}],"security":"Common Stock","published_at":"2020-10-09T23:21:22.000Z","date":"2020-10-09","kind":"exercise","acquired":true,"shares":11649,"price":13.98,"value":162853.02,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on February 28, 2020."}],"balance_after":105276.1404,"source":{"system":"sec-edgar","filing":"0001225208-20-012407","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520820012407/doc4.xml","form_type":"4"}},{"id":3033560,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":125481,"kind":"person","name":"WANG HUIMIN","position":1,"cik":"0001204553","reported_name":"WANG HUIMIN","relationship":{"officer":true,"officer_title":"CVP, Japan & Intercontinental"}}],"security":"Employee Stock Option (Right to Acquire)","published_at":"2020-09-11T21:35:08.000Z","date":"2020-09-11","kind":"exercise","acquired":false,"shares":11649,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on February 28, 2020."}],"balance_after":58257,"derivative":{"exercise_price":13.98,"exercise_date":"2015-05-08","expiration_date":"2021-05-07","underlying":"Common Stock","underlying_shares":11649},"source":{"system":"sec-edgar","filing":"0001225208-20-011444","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520820011444/doc4.xml","form_type":"4"}},{"id":3033559,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":125481,"kind":"person","name":"WANG HUIMIN","position":1,"cik":"0001204553","reported_name":"WANG HUIMIN","relationship":{"officer":true,"officer_title":"CVP, Japan & Intercontinental"}}],"security":"Common Stock","published_at":"2020-09-11T21:35:08.000Z","date":"2020-09-11","kind":"sale","acquired":false,"shares":11339,"price":82.4257,"value":934625.0123,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on February 28, 2020."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"This transaction was executed in multiple trades at prices ranging from $81.88 to $82.83.  The price reported above reflects the weighted average sale price.  The reporting person hereby undertakes to provide, upon request by the SEC staff, the issuer, or a security holder of the issuer, full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":93627.1404,"source":{"system":"sec-edgar","filing":"0001225208-20-011444","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520820011444/doc4.xml","form_type":"4"}},{"id":3033558,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":125481,"kind":"person","name":"WANG HUIMIN","position":1,"cik":"0001204553","reported_name":"WANG HUIMIN","relationship":{"officer":true,"officer_title":"CVP, Japan & Intercontinental"}}],"security":"Common Stock","published_at":"2020-09-11T21:35:08.000Z","date":"2020-09-11","kind":"sale","acquired":false,"shares":310,"price":82.969,"value":25720.39,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on February 28, 2020."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This transaction was executed in multiple trades at prices ranging from $82.96 to $83.04The price reported above reflects the weighted average sale price.  The reporting person hereby undertakes to provide, upon request by the SEC staff, the issuer, or a security holder of the issuer, full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":104966.1404,"source":{"system":"sec-edgar","filing":"0001225208-20-011444","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520820011444/doc4.xml","form_type":"4"}},{"id":3033557,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":125481,"kind":"person","name":"WANG HUIMIN","position":1,"cik":"0001204553","reported_name":"WANG HUIMIN","relationship":{"officer":true,"officer_title":"CVP, Japan & Intercontinental"}}],"security":"Common Stock","published_at":"2020-09-11T21:35:08.000Z","date":"2020-09-11","kind":"sale","acquired":false,"shares":81,"price":83,"value":6723.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on February 28, 2020."}],"balance_after":105276.1404,"source":{"system":"sec-edgar","filing":"0001225208-20-011444","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520820011444/doc4.xml","form_type":"4"}},{"id":3033556,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":125481,"kind":"person","name":"WANG HUIMIN","position":1,"cik":"0001204553","reported_name":"WANG HUIMIN","relationship":{"officer":true,"officer_title":"CVP, Japan & Intercontinental"}}],"security":"Common Stock","published_at":"2020-09-11T21:35:08.000Z","date":"2020-09-11","kind":"exercise","acquired":true,"shares":11649,"price":13.98,"value":162853.02,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on February 28, 2020."}],"balance_after":105357.1404,"source":{"system":"sec-edgar","filing":"0001225208-20-011444","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520820011444/doc4.xml","form_type":"4"}},{"id":3062367,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":125481,"kind":"person","name":"WANG HUIMIN","position":1,"cik":"0001204553","reported_name":"WANG HUIMIN","relationship":{"officer":true,"officer_title":"CVP, Japan & Intercontinental"}}],"security":"Employee Stock Option (Right to Acquire)","published_at":"2020-08-11T23:46:37.000Z","date":"2020-08-11","kind":"exercise","acquired":false,"shares":11649,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on February 28, 2020."}],"balance_after":69906,"derivative":{"exercise_price":13.98,"exercise_date":"2015-05-08","expiration_date":"2021-05-07","underlying":"Common Stock","underlying_shares":11649},"source":{"system":"sec-edgar","filing":"0001225208-20-010508","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520820010508/doc4.xml","form_type":"4"}},{"id":3062366,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":125481,"kind":"person","name":"WANG HUIMIN","position":1,"cik":"0001204553","reported_name":"WANG HUIMIN","relationship":{"officer":true,"officer_title":"CVP, Japan & Intercontinental"}}],"security":"Common Stock","published_at":"2020-08-11T23:46:37.000Z","date":"2020-08-11","kind":"sale","acquired":false,"shares":11649,"price":76.0403,"value":885793.4547,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on February 28, 2020."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This transaction was executed in multiple trades at prices ranging from $75.5800 to $76.4700.  The price reported above reflects the weighted average sale price.  The reporting person hereby undertakes to provide, upon request by the SEC staff, the issuer, or a security holder of the issuer, full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":93708.1404,"source":{"system":"sec-edgar","filing":"0001225208-20-010508","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520820010508/doc4.xml","form_type":"4"}},{"id":3062365,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":125481,"kind":"person","name":"WANG HUIMIN","position":1,"cik":"0001204553","reported_name":"WANG HUIMIN","relationship":{"officer":true,"officer_title":"CVP, Japan & Intercontinental"}}],"security":"Common Stock","published_at":"2020-08-11T23:46:37.000Z","date":"2020-08-11","kind":"sale","acquired":false,"shares":84,"price":76.47,"value":6423.48,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on February 28, 2020."}],"balance_after":105357.1404,"source":{"system":"sec-edgar","filing":"0001225208-20-010508","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520820010508/doc4.xml","form_type":"4"}},{"id":3062364,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":125481,"kind":"person","name":"WANG HUIMIN","position":1,"cik":"0001204553","reported_name":"WANG HUIMIN","relationship":{"officer":true,"officer_title":"CVP, Japan & Intercontinental"}}],"security":"Common Stock","published_at":"2020-08-11T23:46:37.000Z","date":"2020-08-11","kind":"exercise","acquired":true,"shares":11649,"price":13.98,"value":162853.02,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on February 28, 2020."}],"balance_after":105441.1404,"source":{"system":"sec-edgar","filing":"0001225208-20-010508","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520820010508/doc4.xml","form_type":"4"}},{"id":3085190,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":125481,"kind":"person","name":"WANG HUIMIN","position":1,"cik":"0001204553","reported_name":"WANG HUIMIN","relationship":{"officer":true,"officer_title":"CVP, Japan & Intercontinental"}}],"security":"Employee Stock Option (Right to Acquire)","published_at":"2020-07-10T21:55:03.000Z","date":"2020-07-10","kind":"exercise","acquired":false,"shares":11649,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on February 28, 2020."}],"balance_after":81555,"derivative":{"exercise_price":13.98,"exercise_date":"2015-05-08","expiration_date":"2021-05-07","underlying":"Common Stock","underlying_shares":11649},"source":{"system":"sec-edgar","filing":"0001225208-20-009713","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520820009713/doc4.xml","form_type":"4"}},{"id":3085189,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":125481,"kind":"person","name":"WANG HUIMIN","position":1,"cik":"0001204553","reported_name":"WANG HUIMIN","relationship":{"officer":true,"officer_title":"CVP, Japan & Intercontinental"}}],"security":"Common Stock","published_at":"2020-07-10T21:55:03.000Z","date":"2020-07-10","kind":"sale","acquired":false,"shares":9643,"price":67.3029,"value":649001.8647,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on February 28, 2020."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"This transaction was executed in multiple trades at prices ranging from $66.91 to $67.68.  The price reported above reflects the weighted average sale price.  The reporting person hereby undertakes to provide, upon request by the SEC staff, the issuer, or a security holder of the issuer, full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":93792.1404,"source":{"system":"sec-edgar","filing":"0001225208-20-009713","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520820009713/doc4.xml","form_type":"4"}},{"id":3085188,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":125481,"kind":"person","name":"WANG HUIMIN","position":1,"cik":"0001204553","reported_name":"WANG HUIMIN","relationship":{"officer":true,"officer_title":"CVP, Japan & Intercontinental"}}],"security":"Common Stock","published_at":"2020-07-10T21:55:03.000Z","date":"2020-07-10","kind":"sale","acquired":false,"shares":2006,"price":68.2056,"value":136820.4336,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on February 28, 2020."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This transaction was executed in multiple trades at prices ranging from $67.96 to $68.27.  The price reported above reflects the weighted average sale price.  The reporting person hereby undertakes to provide, upon request by the SEC staff, the issuer, or a security holder of the issuer, full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":103435.1404,"source":{"system":"sec-edgar","filing":"0001225208-20-009713","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520820009713/doc4.xml","form_type":"4"}},{"id":3085187,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":125481,"kind":"person","name":"WANG HUIMIN","position":1,"cik":"0001204553","reported_name":"WANG HUIMIN","relationship":{"officer":true,"officer_title":"CVP, Japan & Intercontinental"}}],"security":"Common Stock","published_at":"2020-07-10T21:55:03.000Z","date":"2020-07-10","kind":"exercise","acquired":true,"shares":11649,"price":13.98,"value":162853.02,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on February 28, 2020."}],"balance_after":105441.1404,"source":{"system":"sec-edgar","filing":"0001225208-20-009713","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520820009713/doc4.xml","form_type":"4"}}],"next_cursor":"2020-07-10T21:55:03.000000Z,3085187"}